Novartis is expanding the Swiss pharma giant’s optogenetics portfolio with the acquisition of gene therapy company Arctos Medical.
If you are not happy with the results below please do another search
50 search results for:
The U.S. Food and Drug Administration on Sept. 21 approved Incyte Corp.’s cream Opzelura for treating the inflammatory skin condition atopic dermatitis, commonly called eczema, in adolescents and adults.
Dr. Bethany Valente, founder and managing partner of Tempo7 LLC, discusses the challenges that biotech and pharma-based businesses face as they work to create more efficient development time frames for product, therapy, or drug development. Dr. Valente says open innovation helps in resolving some of these challenges.
AbelsonTaylor promoted Dave Schafer to director of digital production and quality assurance.
Shares of Verrica Pharmaceuticals plunged after the company received a Complete Response Letter from the U.S. Food and Drug Administration for an experimental treatment for molluscum contagiosum (molluscum).
Positive final results from the Phase III COSMIC-311 trial for Cabometyx (cabozantinib) were reported by Exelixis for patients diagnosed with previously treated radioactive iodine-refractory differentiated thyroid cancer.
September 20, 2021, marked a grisly milestone for the United States, recording more American deaths from Covid-19 than from the 1918–1919 Spanish flu.
Johnson & Johnson said Sept. 21 a second shot of the company’s Covid-19 vaccine given about two months after the first increased its effectiveness to 94 percent in the United States against moderate to severe forms of the disease.
Genmab A/S and Seagen Inc. announced that the U.S. Food and Drug Administration granted accelerated approval to Tivdak (tisotumab vedotin-tftv), the first approved antibody-drug conjugate for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
Paris-based Jeito Capital announced the final close on its first fund, which is the largest venture capital fund in Europe focused on life sciences.